Market Closed -
Saudi Arabian S.E.
13:20:01 26/06/2024 BST
|
5-day change
|
1st Jan Change
|
21
SAR
|
-0.47%
|
|
+1.84%
|
-5.41%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,800
|
12,330
|
14,018
|
16,591
|
16,757
|
15,851
|
-
|
-
|
Enterprise Value (EV)
1 |
12,034
|
12,552
|
11,708
|
15,145
|
15,930
|
15,323
|
15,114
|
14,988
|
P/E ratio
|
17.8
x
|
137
x
|
12.3
x
|
53.6
x
|
148
x
|
26
x
|
14
x
|
13
x
|
Yield
|
6.25%
|
3.65%
|
4.01%
|
6.82%
|
4.5%
|
5.06%
|
6.57%
|
6.94%
|
Capitalization / Revenue
|
1,452,647
x
|
2,017,090
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
1,618,677
x
|
2,053,337
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
10.8
x
|
9.7
x
|
6.37
x
|
35.8
x
|
127
x
|
24.6
x
|
12.8
x
|
11.8
x
|
EV / FCF
|
5.36
x
|
-
|
54
x
|
32
x
|
372
x
|
20.7
x
|
11.3
x
|
11.3
x
|
FCF Yield
|
18.6%
|
-
|
1.85%
|
3.12%
|
0.27%
|
4.84%
|
8.89%
|
8.84%
|
Price to Book
|
1.59
x
|
1.92
x
|
1.91
x
|
1.55
x
|
1.67
x
|
1.59
x
|
1.57
x
|
1.54
x
|
Nbr of stocks (in thousands)
|
450,000
|
450,000
|
450,000
|
754,800
|
754,800
|
754,800
|
-
|
-
|
Reference price
2 |
24.00
|
27.40
|
31.15
|
21.98
|
22.20
|
21.00
|
21.00
|
21.00
|
Announcement Date
|
29/01/20
|
01/02/21
|
27/01/22
|
13/03/23
|
01/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
|
7,435
|
6,113
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
1,114
|
1,294
|
1,838
|
422.9
|
125.8
|
623.9
|
1,183
|
1,273
|
EBIT
1 |
247.8
|
417.1
|
1,837
|
422.1
|
125
|
579.6
|
1,130
|
1,266
|
Operating Margin
|
3.33%
|
6.82%
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,847
|
467.5
|
180.8
|
775
|
1,312
|
1,391
|
Net income
1 |
605.3
|
91.64
|
1,136
|
277.4
|
112
|
689.5
|
1,194
|
1,266
|
Net margin
|
8.14%
|
1.5%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
1.350
|
0.2000
|
2.530
|
0.4100
|
0.1500
|
0.8070
|
1.497
|
1.612
|
Free Cash Flow
1 |
2,244
|
-
|
216.6
|
472.6
|
42.88
|
742
|
1,343
|
1,324
|
FCF margin
|
30.18%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
201.38%
|
-
|
11.79%
|
111.73%
|
34.09%
|
118.94%
|
113.54%
|
104.02%
|
FCF Conversion (Net income)
|
370.7%
|
-
|
19.06%
|
170.33%
|
38.28%
|
107.61%
|
112.43%
|
104.58%
|
Dividend per Share
2 |
1.500
|
1.000
|
1.250
|
1.500
|
1.000
|
1.062
|
1.380
|
1.458
|
Announcement Date
|
29/01/20
|
01/02/21
|
27/01/22
|
13/03/23
|
01/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
272.3
|
372.3
|
299.5
|
57.93
|
-307.7
|
-237.5
|
219.3
|
24
|
35
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
121.6
|
234.9
|
284.2
|
54.8
|
-296.4
|
-241.5
|
222.4
|
11
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.2700
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/01/22
|
10/05/22
|
04/08/22
|
03/11/22
|
13/03/23
|
10/05/23
|
05/11/23
|
01/02/24
|
12/05/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,234
|
222
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
2,310
|
1,445
|
827
|
527
|
737
|
863
|
Leverage (Debt/EBITDA)
|
1.108
x
|
0.1712
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,244
|
-
|
217
|
473
|
42.9
|
742
|
1,343
|
1,325
|
ROE (net income / shareholders' equity)
|
8.84%
|
1.39%
|
16.5%
|
3.08%
|
1.92%
|
6.02%
|
11.2%
|
11.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
9.68%
|
2.37%
|
1.03%
|
6.4%
|
11%
|
11.5%
|
Assets
1 |
-
|
-
|
11,738
|
11,683
|
10,894
|
10,773
|
10,859
|
11,061
|
Book Value Per Share
2 |
15.10
|
14.20
|
16.30
|
14.20
|
13.30
|
13.20
|
13.40
|
13.60
|
Cash Flow per Share
2 |
5.060
|
3.990
|
0.4800
|
0.7000
|
0.0600
|
1.130
|
1.340
|
1.330
|
Capex
1 |
32.6
|
25.5
|
0.89
|
0.9
|
0.74
|
0.87
|
0.87
|
0.87
|
Capex / Sales
|
0.44%
|
0.42%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/01/20
|
01/02/21
|
27/01/22
|
13/03/23
|
01/02/24
|
-
|
-
|
-
|
Average target price
22.92
SAR Spread / Average Target +9.14% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.41% | 4.24B | | +2.94% | 103B | | -11.86% | 59.25B | | +72.86% | 47.15B | | +11.16% | 37.09B | | +0.74% | 31.09B | | +4.74% | 18.82B | | +14.69% | 16.97B | | +9.34% | 13.67B | | -3.67% | 12.77B |
Other Commodity Chemicals
|